Supreme Court set to consider cert. petition on generic drug use of “skinny labels” to avoid infringing method of use patents. Court expected to consider cert. petition during court conference on May ...

WASHINGTON — The Supreme Court gave the pharmaceutical industry two victories, shielding the makers of generic drugs from most lawsuits by injured patients and declaring that drugmakers had a ...

Federal law requires generic drugs to maintain the same labeling as the brand-name products they reproduce, including warnings of potential side effects. In a 5-4 decision, the court said patients ...

Richmond, VA (WRIC) – The Federal Drug Administration wants the makers of generic drugs to unilaterally update warning labels on their drugs, something they are not currently required to do. Do you ...

The federal government re-ignited a controversial proposal to give generic drug makers the power to unilaterally update product labels to reflect new safety information, a proposal that drew criticism ...